Alphatec, which designs and manufactures products for the surgical treatment of spine disorders, lowered the price range for its IPO from $13-15 to $11-12 on Thursday and cut its proposed market cap by 18% to $390 million. Lead manager Deutsche Bank Securities still plans to price the IPO on Thursday evening.
